News + Press

Fuld + Company Announces New, Senior Hire for Energy Practice

Posted July 11, 2019| Fuld + Company

Keith McWhorter, MBA, Brings Strong Domain Knowledge, Strategy, Analysis and Research Capabilities to the Firm

Keith McWhorter | Director, Fuld + CompanyBoston, Mass. July 11, 2019—Fuld + Company, a global competitive strategy consultancy, today announced the recent appointment of Keith McWhorter as a Director, to oversee the firm’s robust energy consulting practice. In this capacity, McWhorter will be responsible for practice area growth, managing client relationships and deliverables, focusing on custom research and analysis projects, and overseeing a team of consultants.

McWhorter, who has nearly a decade of experience in the energy sector, joins Fuld + Company from global information provider, IHS Markit. Over the past 7 years, McWhorter advanced in roles and responsibility at IHS Markit, and most recently served as Principal Research Analyst for its North American Natural Gas service. In this role, he conducted regional analysis in the US and Canada, forecasted natural gas prices, conducted market and production analysis, and evaluated infrastructure needs for bringing gas to new markets.  During his tenure at IHS Market, he worked with the power, gas, coal and renewables commercial strategy team to help develop commercial analytics tools.

“We are thrilled to welcome Keith to Fuld as his domain expertise will reinforce the strategic analysis and robust insights we currently deliver to our Fortune 500 clients,” said Diane Borska, Fuld + Company CEO. “Keith’s previous history working in energy markets—from solar to natural gas—will help bring a new degree of expertise and analytical thinking to client engagements. Beyond his experience, we’re excited about Keith’s position as a leader, where he has an opportunity to use his diverse background to drive practice growth and lead client projects.”

Prior to IHS Market, McWhorter acted as a consultant and spearheaded several market research projects and financial modeling projects for various companies; with a special focus on solar energy.

“I’m excited to join Fuld + Company for a number of reasons not the least of which is the firm’s reputation for building long-term partnerships with its clients,” said McWhorter. “In this role, I have the opportunity to continue deepening these relationships and providing critical decision support with an eye to the client’s unique business goals and operating models. I look forward to making an immediate impact.”

Keith McWhorter, a resident of Milton, Mass. earned his MBA from Babson College’s Franklin W. Olin School of Business and his bachelor’s degree from Williams College. Keith’s hiring announcement comes on the heels of Fuld + Company’s recent appointment of Senior Consultant, Tom Carugati, whose graduate work focused on the energy transition will deliver significant value in Fuld’s growing energy practice.


About Fuld + Company

Fuld + Company is a competitive strategy consultancy that helps clients anticipate competitive activity, see beyond market disruptions and develop or refine robust business strategies. Through research and evidence-based analysis, Fuld + Company delivers sound expertise to solve complex and tactical challenges for its Global Fortune 1000 clients.  Fuld + Company is celebrating its 40th year in business and is a pioneer in competitive strategy consulting.  Its leaders have been recognized by top-tiered publications such as: Fortune, The Harvard Business Review & Fast Company. 


Tags: , , ,

Related Resources

Read More

Fuld + Company Welcomes Health & Life Sciences Practice Leader, Michael Ratcliffe

Michael Ratcliffe brings both deep industry expertise and intelligence and strategy consulting capabilities to the firm. Boston, Mass. November 26, […]

Read More

Analysis Of The Trastuzumab Biosimilar Market As Herceptin Exclusivity Nears An End

To expand on the Fuld + Company, Pharma Companies to Watch Report, Analyst Robert Browne drilled in on the Biosimilar Marketplace in […]

Read More

Evolution In Prostate Cancer Diagnostics Creates New Opportunities For Medtech

In the US, prostate cancer remains a challenge for men’s health, with approximately 174,650 new cases expected in 2019, third […]

Subscribe to our mailing list for our latest updates: